Is Biofrontera AG halal to invest in?

As of July 2026, Biofrontera AG B8FK.DE is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Biofrontera AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biofrontera AG using these criteria to determine its compliance status.

Can Muslims buy shares of Biofrontera AG?

Muslim investors may consider investing in Biofrontera AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Biofrontera AG classified as HALAL?

Musaffa determines the Shariah status of Biofrontera AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Biofrontera AG updated?

The Shariah compliance status of Biofrontera AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Biofrontera AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Biofrontera AG?

You can check the latest Shariah compliance status of Biofrontera AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Biofrontera AG B8FK.DE

Last Updated: Jul 21, 12:00 AM·XETRA

B8FK.DE Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Biofrontera AG is classified as halal.

HALAL

Report Source: 2025 3rd Quarter Report

Biofrontera AG. Stock Analysis B8FK.DE

Germany Health Care Nano Cap Report: Q3, 2025

Biofrontera AG engages in the research, development, and marketing of dermatological products. The firm develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and warts; PDT lamp BF-RhodoLED, used after the Ameluz treatment to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itching, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The firm is also engaged in clinical development of two drug candidates: BF-derm1, a tablet with inhibitor blocking the synthesis of histamine in cells, a cause of allergic reactions; and BF1, a selective serotonin receptor to prevent migraines. The firm operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MM Familien KG.

Key Statistics of Biofrontera AG (B8FK.DE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€2.36€2.37

Today's Open

€2.36

Volume

2250.00

P/E Ratio (TTM)

52 Week Range

€2.21€2.96

Market Cap

14.65M

Avg. Volume

309.95

Dividend Yield

Financial Metrics & Statements of Biofrontera AG (B8FK.DE)

Super Investors Invested in Biofrontera AG (B8FK.DE)

FAQ's for Biofrontera AG (B8FK.DE)

As of July 2026, Biofrontera AG B8FK.DE is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biofrontera AG using these criteria to determine its compliance status.
Muslim investors may consider investing in Biofrontera AG if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Biofrontera AG by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Biofrontera AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Biofrontera AG on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.